Daniel Lee

Daniel Lee is the President of US Operations at Tissue Regenix. Daniel has over 20 years of experience in the medical device industry, including previous positions as Chief Operating Officer at Aperion Biologics, Director of Marketing at Smith & Nephew Endoscopy, and President and CEO at Scaffold Biologics. Prior to their current role, Daniel served as the Director of Marketing at OsteoBiologics, which was acquired by Smith & Nephew in 2006. Daniel began their career in the medical device industry as a design engineer and manager at U.S. Surgical Corp.

Daniel Lee has a Bachelor's degree in Engineering Science from The Johns Hopkins University, and a Master's degree in Biomedical Engineering from the University of Alabama at Birmingham. Daniel is also certified by the American Association of Tissue Banks in Clinical Tissue Banking Specialist (CTBS).

Daniel Lee reports to Gareth Jones, Interim CEO. They are on a team with Joel Pickering - President, TRX BioSurgery, Mike Izon - R&D Director.